• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

成人慢性肾脏病患者分枝杆菌结核感染和疾病的预防和管理指南。

Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease.

出版信息

Thorax. 2010 Jun;65(6):557-70. doi: 10.1136/thx.2009.133173.

DOI:10.1136/thx.2009.133173
PMID:20522863
Abstract

Guidelines have been compiled by the Joint Tuberculosis Committee of the British Thoracic Society for the prevention and management of Mycobacterium tuberculosis infection and disease in patients with all grades of renal impairment.

摘要

指南由英国胸科学会结核委员会为预防和管理所有级别肾功能损害患者的结核分枝杆菌感染和疾病而编写。

相似文献

1
Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease.成人慢性肾脏病患者分枝杆菌结核感染和疾病的预防和管理指南。
Thorax. 2010 Jun;65(6):557-70. doi: 10.1136/thx.2009.133173.
2
An update on the management of latent tuberculosis infection and active disease in patients with chronic kidney disease.慢性肾脏病患者潜伏性结核感染和活动性疾病管理的最新进展。
Pol Arch Intern Med. 2017 Aug 24;127(10):681-686. doi: 10.20452/pamw.4093.
3
Tuberculosis and chronic kidney disease: an emerging global syndemic.结核病和慢性肾脏病：一种新出现的全球综合征。
Kidney Int. 2016 Jul;90(1):34-40. doi: 10.1016/j.kint.2016.01.034. Epub 2016 May 10.
4
[Who must have tuberculosis screening? Characteristics of risk patients].[哪些人必须进行结核病筛查？高危患者的特征]
MMW Fortschr Med. 2013 May 16;155(9):16-8.
5
Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis.耐多药结核病儿童接触者中潜伏性结核感染的管理
Pediatr Infect Dis J. 2014 Jun;33(6):664-6. doi: 10.1097/INF.0000000000000260.
6
[Tuberculosis and nontuberculous mycobacterial infections].[结核病和非结核分枝杆菌感染]
Dtsch Med Wochenschr. 2011 Apr;136(14):691-4. doi: 10.1055/s-0031-1274565. Epub 2011 Mar 29.
7
A current approach to the management of tuberculosis infection.一种当前用于管理结核感染的方法。
Curr Clin Top Infect Dis. 2000;20:209-31.
8
Mycobacterial Infections in Patients With Chronic Kidney Disease and Kidney Transplantation.慢性肾脏病和肾移植患者的分枝杆菌感染。
Adv Chronic Kidney Dis. 2019 Jan;26(1):35-40. doi: 10.1053/j.ackd.2018.09.004.
9
A comparison between interferon gamma release assays and the tuberculin skin test in the contact tracing of patients with chronic kidney disease.
Thorax. 2011 Aug;66(8):729-30; author reply 730. doi: 10.1136/thx.2010.149088. Epub 2010 Oct 14.
10
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.潜伏性结核分枝杆菌感染的管理：世界卫生组织针对结核病低负担国家的指南
Eur Respir J. 2015 Dec;46(6):1563-76. doi: 10.1183/13993003.01245-2015. Epub 2015 Sep 24.

引用本文的文献

1
Screening for latent tuberculosis infection in patients with chronic kidney disease: a review of evidence and current practice in the UK.慢性肾脏病患者潜伏性结核感染的筛查：英国证据与当前实践综述
Clin Kidney J. 2025 Jun 19;18(7):sfaf197. doi: 10.1093/ckj/sfaf197. eCollection 2025 Jul.
2
Analysis of the clinical characteristics of 100 patients who developed tuberculosis after renal transplantation.100例肾移植后发生结核病患者的临床特征分析。
BMC Infect Dis. 2025 Jun 4;25(1):795. doi: 10.1186/s12879-025-11197-7.
3
Clinical presentation and outcome of tuberculosis in chronic kidney disease stage 4 & 5 from a high TB burden country.
来自结核病高负担国家的慢性肾脏病4期和5期患者的结核病临床表现及转归
PLoS One. 2025 Apr 2;20(4):e0320907. doi: 10.1371/journal.pone.0320907. eCollection 2025.
4
Adequacy of recommendations for adverse event management in national and international treatment guidelines for rifampicin-susceptible tuberculosis: a systematic review.利福平敏感型结核病国家和国际治疗指南中不良事件管理建议的充分性：一项系统评价
EClinicalMedicine. 2025 Mar 18;82:103148. doi: 10.1016/j.eclinm.2025.103148. eCollection 2025 Apr.
5
Factors associated with time to relapse in pulmonary tuberculosis patients using penalized Cox models.基于惩罚 Cox 模型的肺结核患者复发时间相关因素分析。
BMC Res Notes. 2024 Nov 11;17(1):333. doi: 10.1186/s13104-024-06986-3.
6
Role of interferon-gamma release assay for screening and monitoring of latent tuberculosis infection in kidney transplant recipients.γ-干扰素释放试验在肾移植受者潜伏结核感染筛查和监测中的作用。
BMC Infect Dis. 2024 Oct 7;24(1):1110. doi: 10.1186/s12879-024-09990-x.
7
Tuberculosis in kidney transplant candidates and recipients.肾移植候选者和接受者中的结核病
World J Transplant. 2024 Sep 18;14(3):96225. doi: 10.5500/wjt.v14.i3.96225.
8
ISCCM Position Statement on the Approach to and Management of Critically Ill Patients with Tuberculosis.国际危重症医学会关于重症结核病患者治疗与管理方法的立场声明
Indian J Crit Care Med. 2024 Aug;28(Suppl 2):S67-S91. doi: 10.5005/jp-journals-10071-24783. Epub 2024 Aug 10.
9
Effect of chronic kidney disease on adverse drug reactions to anti-tubercular treatment: a retrospective cohort study.慢性肾脏病对抗结核治疗药物不良反应的影响：一项回顾性队列研究。
Ren Fail. 2024 Dec;46(2):2392883. doi: 10.1080/0886022X.2024.2392883. Epub 2024 Aug 21.
10
Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis.精准医学策略改善结核病患者的异烟肼治疗。
Eur J Drug Metab Pharmacokinet. 2024 Sep;49(5):541-557. doi: 10.1007/s13318-024-00910-7. Epub 2024 Aug 17.